Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02716272
Brief Title: Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients (MAPS2)

First Submitted : March 9, 2016
First Submitted that Met QC Criteria : March 17, 2016
First Posted : March 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 9, 2021
Last Update Posted : February 10, 2021